HMOX2-driven crosstalk between vascular aging and heart failure

Jinze Li , Guiting Zhou, Qiaochu Wang, Zhixuan Song, Jiantao Liu, Changzao Shen, Chuanjin
Luo,Dawei Wang

Abstract

The molecular mechanisms linking vascular aging (VA) and heart failure (HF) remain elusive, hindering therapeutic strategies for their comorbidity. This study aimed to identify key biomarkers and pathways potentially involved in VA-HF synergy using integrative computational approaches.

Introduction

Heart failure (HF) remains a global health crisis, affecting over 64 million individuals worldwide, with escalating morbidity and mortality despite advances in therapeutic strategies [1, 2 ]. Emerging evidence highlights vascular aging (VA), a pathological process characterized by endothelial dysfunction, arterial stiffness, and chronic inflammation, as a contributor to HF progression [3, 4 ]. Vascular aging is defined as the progressive degenerative changes in the morphology and function of blood vessels that occur with increasing age.

Methods

The raw expression profile datasets of HF patients were downloaded from the GEO database (https://www.ncbi.nlm.nih.gov/geo/), specifically the GSE57338 dataset (platform: GPL11532), which includes 136 healthy arterial tissue samples and 177 HF tissue samples. Vascular aging-related biomarkers were retrieved from the GeneCard database, yielding a total of 16,243 potential biomarkers.

Results

In the GSE57338 dataset, 450 DEGs were identified in the HF group compared to the control group, including 248 downregulated and 202 upregulated DEGs (Fig 1A, B). WGCNA was performed on the same dataset, with the optimal soft-thresholding power determined to be 10.

Discussion

The present study suggests a potential molecular axis linking VA and HF through integrative bioinformatics and explainable ML. By intersecting HF-associated DEGs, vascular aging biomarkers, and co-expression networks, we identified 272 CGs enriched in pathways potentially involved in vascular-cardiac crosstalk.

Acknowledgments

We gratefully acknowledge the Lingnan Medical Research Center of Guangzhou University of Chinese Medicine for providing technical support.

Citation: Li J, Zhou G, Wang Q, Song Z, Liu J, Shen C, et al. (2026) HMOX2-driven crosstalk between vascular aging and heart failure: A multimodal bioinformatics and explainable machine learning approach with experimental validation. PLoS One 21(9): e0357886. https://doi.org/10.1371/journal.pone.0357886

Editor: Wan-Tien Chiang, Augusta University, TAIWAN

Received: March 16, 2026; Accepted: August 24, 2026; Published: September 15, 2026

Copyright: © 2026 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: The data presented in this study are openly available in Gene Expression Omnibus (GEO) (URL: https://www.ncbi.nlm.nih.gov/geo/,accessed on May 30, 2025).

Funding: This work was supported by the Guangdong Provincial Laboratory of Traditional Chinese Medicine Project [grant number HQL2024PZ028]; the National Key Laboratory of Traditional Chinese Medicine Syndrome [grant number 09005651007]; the Foundation Strengthening Project of Guangzhou University of Chinese Medicine [grant number GZY2025GB0109]; the State Key Laboratory of Traditional Chinese Medicine Syndrome [grant number SKLKY2024B0002]; the Guangdong Provincial National Comprehensive Reform Demonstration Zone for Traditional Chinese Medicine Science and Technology Co-construction Project [grant number GZY-KJS-GD-2025-012]; the Guangdong Special Support Program for Leading Talents Project [grant number 0820250113]; the Guangdong Basic and Applied Basic Research Foundation Project [grant number 2026A1515012068]; the 2025 National Comprehensive Reform Demonstration Zone for Traditional Chinese Medicine Science and Technology Co-construction Project [grant number GZY-KJS-GD-2025-058]; the Research Project of Shunde Hospital of Guangzhou University of Chinese Medicine in 2025 [grant number YNZX2025007]; and the Guangdong Provincial Administration of Traditional Chinese Medicine Scientific Research Project on Traditional Chinese Medicine [grant number 20254021]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Abbreviations: ANOVA, Analysis Of Variance; AUC, Area Under The Curve; BP, Biological Process; CC, Cellular Component; CGs, Consensus Genes; cGMP-PKG, Cyclic Guanosine Monophosphate-Dependent Protein Kinase; DEGs, Differentially Expressed Genes; DOX, Doxorubicin; EF, Ejection Fraction; FDR, False Discovery Rate; FS, Fractional Shortening; GEO, Gene Expression Omnibus; GO, Gene Ontology; HASMC, Human Aortic Smooth Muscle Cells; HF, Heart Failure; KEGG, Kyoto Encyclopedia Of Genes And Genomes; LASSO, Least Absolute Shrinkage And Selection Operator; MAD, Median Absolute Deviation; MF, Molecular Function; ML, Machine Learning; NO, Nitric Oxide; PBS, Phosphate-Buffered Saline; PPAR, Peroxisome Proliferator-Activated Receptor; qPCR, Quantitative Polymerase Chain Reaction; RF, Random Forest; ROC, Receiver Operating Characteristic; ROS, Reactive Oxygen Species; RT-qPCR, Reverse Transcription Quantitative Pcr; SA-β-gal, Senescence-Associated Beta-Galactosidase; SD, Standard Deviation; SHAP, Shapley Additive Explanations; siRNA, Small Interfering Rna; VA, Vascular Aging; VSMC, Vascular Smooth Muscle Cells; WGCNA, Weighted Gene Co-Expression Network Analysis; XGBoost, Extreme Gradient Boosting